New Amsterdam Pharma
Kelley Gorbe, PharmD, BCMAS, currently serves as a Senior Medical Science Liaison at NewAmsterdam Pharma since March 2024. Previously, Kelley held the position of Director of Global Medical & Clinical Affairs at Quanta Dialysis Technologies from December 2021 to March 2024, and worked as a Senior Medical Science Liaison for Nephrology at Ardelyx, Inc. from December 2020 to December 2021. Additional experience includes a role as a Medical Science Liaison for Nephrology at AstraZeneca in 2020, and various clinical pharmacist positions at St. John Providence and Henry Ford Health System. Kelley’s earlier roles include Associate Director of Global Medical Affairs at Baxter International and Clinical Pharmacist Specialist in Cardiology at Detroit Medical Center. Kelley began a career in healthcare with a Doctor of Pharmacy degree from the University of Michigan, completed in 2000.
This person is not in any teams
This person is not in any offices
New Amsterdam Pharma
1 followers
Founded in 2019 by the venture capital firm Forbion and John Kastelein, NewAmsterdam Pharma is a privately held, clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies are not tolerated or have been unsuccessful.